AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

EyePoint Pharmaceuticals, Inc.

$0.35 -$17.13 (-98.01%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$0.38
Day Range
$0.34$0.38
Year Range
$0.34$19.11
Market Cap
29.21M
AVG Volume
6.9M
Trailing/Forward PE
-0.09/-
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-04
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
020M40M60M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EYPT Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
26 Q22.79M
26 Q17.62M
25 Q431.37M
25 Q342.34M
25 Q251.9M
25 Q156.04M
24 Q443.27M
24 Q345.71M
24 Q250.39M
24 Q150.02M
Net Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EYPT Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
26 Q2-306.64M
26 Q1-271.6M
25 Q4-231.96M
25 Q3-205.75M
25 Q2-175.38M
25 Q1-146.78M
24 Q4-130.87M
24 Q3-103.57M
24 Q2-86.82M
24 Q1-78.92M
Operating Income (USD) · TTM
-400M-300M-200M-100M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EYPT Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
26 Q2-316.98M
26 Q1-281.82M
25 Q4-243.43M
25 Q3-218.33M
25 Q2-189.05M
25 Q1-161.37M
24 Q4-145.85M
24 Q3-116.97M
24 Q2-98.62M
24 Q1-86.83M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: EYPT

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 4 Nov 2026.

EyePoint Pharmaceuticals, Inc.
EYPT
Stockpicker

Video analysis: EYPT

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: EYPT

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.